Drawing for YANIKLER

USPTO serial 85009184

YANIKLER

Reviewed by CopyMark Law Group

Reg. 3947037Status 710
Filing date
Status date
Registration date
Apr 19, 2011
Examiner
CHOSID, ROBIN S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with YANIKLER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adrienne L. White

ADRIENNE L. WHITE WRB-IP LLPPO BOX 476WADSWORTH, OH 44282-0476UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical and veterinary preparations, namely, medicines, vaccines, and serums for the testing, prevention, treatment and diagnosis of tumor precursors, benign and malignant tumors, in particular, warts, genital warts, neuronal tumors, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, crohn's disease, lupus erythematosus and multiple sclerosis, neurodegenerative disorders, in particular alzheimer's disease, huntington's disease, multiple sclerosis, parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or creutzfeldt-jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, bechterew's disease, fibromyalgia and lupus erythematodes, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and obesity, skin diseases, in particular warts, genital warts, bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections, and ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and retinoblastoma; all of the above consisting of low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, t-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administrationSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 24, 2017C8..CANCELLED SEC. 8 (6-YR)—
Apr 19, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 1, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 1, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 22, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 21, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 21, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 21, 2010ALIEASSIGNED TO LIE—
Nov 29, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2010GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
May 29, 2010GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
May 29, 2010CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
May 27, 2010DOCKASSIGNED TO EXAMINER—
Apr 13, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 12, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance